Sanifit to Participate in the 2021 ICR Conference

  Palma, Spain and San Diego, USA, January 7, 2021 – Sanifit, a clinical-stage biopharmaceutical company focused on developing treatments for calcification disorders, today announced its participation in the 2021 ICR Conference. Joan Perelló, Ph.D., Chief Executive Officer, will participate in a virtual fireside chat led by Christopher Raymond, Managing Director and Senior Research Analyst at … Continue reading Sanifit to Participate in the 2021 ICR Conference